Operating profit of Novo Nordisk 2009-2019

The operating profit of Novo Nordisk, a Danish pharmaceutical company focused on is diabetes medication, peaked in 2015, at around 49.4 billion Danish kroner. Through to 2018, the operating profit fluctuated in the range of 47.2 to 49.4 billion Danish kroner, but increased significantly in 2019 to roughly 52.5 billon Danish kroner.

Operating profit of Novo Nordisk from 2009 to 2019

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% Discount until June 30th
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

February 2020

Region

Denmark

Survey time period

2009 to 2019

Supplementary notes

Some figures have been taken from previous publications.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Pharmaceutical industry in Denmark "

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.